# Pizarra — PT-pseudo_4edb17f79e46 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_4edb17f79e46
Task: 1

Encounter: Urology - outpatient on 25 Feb 2025.
Referrer: Dr. S. de Vries (GP).
Type: Re-evaluation - prior negative biopsy.

Clinical data (read-only — values loaded from the record):
  - 54-year-old male
  - PSA: 9.2 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.16 ng/mL²
  - PSA velocity: 1.51 ng/mL/yr
  - Prior PSA: 7.5 ng/mL
  - Prostate volume: 57.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Negative (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7709042 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 9.2 ng/mL. PI-RADS 4. PSAD 0.16. Prostate volume 57 mL. csPCa 0.77.

Vitals: weight 72 kg, height 177 cm, BMI 23.0, BP 161/76 mmHg, HR 73 bpm. Smoking: Non-smoker.

Chief complaint: A documented upward trajectory in prostate-specific antigen levels alongside a previously negative biopsy necessitates clinical re-assessment.

History: This 54-year-old gentleman works as a retired farmer residing in a ground-floor apartment shared with his partner. He originally entered the diagnostic pathway in May 2023 due to an elevated PSA. A non-smoker with no comorbidities or active medications, he maintains an active routine that includes running five kilometres three times weekly and consumes approximately thirteen units of alcohol each week. Lower urinary tract symptoms remain minimal, reflected by an IPSS score of five, and he explicitly denies haematuria, unexplained weight loss, or bone pain. His surgical past includes a childhood appendectomy and a right knee arthroscopy for a meniscal tear conducted fifteen years prior. Recent visits to an audiology clinic for standard hearing screening noted occasional mild tinnitus, though he otherwise reports feeling well. He commutes roughly sixty minutes by train to reach this facility. A prior biopsy returned negative, and digital rectal examination is normal.

Physical examination: On examination, digital rectal assessment is normal; the prostate reveals a symmetrically enlarged contour, smooth and firm consistency, with no palpable nodules or asymmetry. General inspection shows a blood pressure of 161/76 mmHg with a regular pulse of 73 beats per minute. Peripheral lymphadenopathy and abdominal masses are notably absent.

Patient info: retired farmer; Married; Lives in ground-floor apartment with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 13 units / week; exercise Running 3x/week, 5 km; IPSS score: 5/35 (mild LUTS).

Recent other appointments: Audiology — hearing test.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.75 +/- 0.17   (95% CI 0.36-0.98)

Where the uncertainty comes from:
  - aleatoric  dA = 0.14  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.09  (few labelled cases resemble this one)
  - 6.8 effective neighbours out of 10; 4 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {yes}

TIER 'supports': A +/- dA does not cross 0.5, but A +/- 1.96*dA does. There is a direction, not a conclusion. Measured accuracy in this tier: 0.67. Treat it as a weighted vote, not as a decision.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=4.0, bx_ord=1.0, psa=9.2, age=54.0, psad=0.16, dre_ord=0.0, vol=57.0, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
  The statistical recommender only used the structured panel. It could not weigh the PSA velocity (1.51 ng/mL/yr) and the PSA trend (prior PSA 7.5 ng/mL), which indicate a significant recent rise, against the prior negative biopsy status. It also missed the context provided by the mpMRI report (PI-RADS 4) and the specific details from the laboratory panel, which are crucial for risk stratification.

WHY THE SUGGESTION COULD BE WRONG
  The prior suggests biopsy (0.75), but the case presents a contradiction: a PI-RADS 4 (intermediate risk) combined with a prior negative biopsy. The PSA velocity of 1.51 ng/mL/yr suggests progression, which might argue for biopsy, but the prior negative result complicates this. The wide interval (95% CI 0.36-0.98) suggests high uncertainty, meaning the prior's suggestion is highly sensitive to missing data.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
  <document> radiology / mpMRI report -> If the report suggests a high likelihood of clinically significant cancer despite PI-RADS 4, it would strongly push towards biopsy.
  <document> PSA history (trend) -> If the trend shows a very steep recent rise, it would increase the urgency for a biopsy.
  <document> previous GP / urology consultation notes -> If these notes detail any specific clinical concerns or follow-up plans related to the prior negative biopsy, it would contextualize the current decision.
  <document> laboratory results (full panel) -> If the lab panel shows any markers (e.g., PSA density, other markers) that significantly alter the risk profile, it would refine the decision.

## [4] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
  One block per document you opened. Quote the values and phrases that matter, verbatim and with units. Numbers, lesion descriptions, dates, explicit radiologist or clinician recommendations. Do not paraphrase a number. If a document turned out to be uninformative, say so in one line.

  **radiology / mpMRI report**
  {"case_id": "PT-pseudo_4edb17f79e46", "radiology_report": "Subject: Multiparametric MRI Prostate | Date: 10 Feb 2025 | Reporting Unit: Antoni van Leeuwenhoek Imaging Department\n\nClinical Indication:\nA re-evaluation is required following an elevated PSA value of 9.2 ng/mL and a previously negative biopsy.\n\nFINDINGS:\nThe gland measures 57.0 mL in total volume. A discrete abnormality sits at the base-to-mid junction of the left peripheral zone, spanning roughly 12 mm. T2-weighted sequences show the mass as hypointense compared to adjacent tissue. Diffusion-weighted imaging highlights pronounced restricted diffusion, corroborated by low ADC signal. Post-contrast phases capture early, focal enhancement within the abnormality. Benign nodular hyperplasia characterizes the transition zone, lacking suspicious characteristics. There is no evidence of extraprostatic extension or seminal vesicle invasion, and pelvic lymph nodes appear normal.\n\nIMPRESSION:\nPI-RADS 4 lesion located in the left peripheral zone, approximately 12 mm. Prostate volume 57.0 mL, yielding a PSA density of 0.16 ng/mL/mL. csPCa predicted probability 0.7709042."}

  **psa_trend**
  {"case_id": "PT-pseudo_4edb17f79e46", "psa_trend": [{"date": "May 2023", "val": 8.4}, {"date": "Oct 2023", "val": 2.6}, {"date": "Apr 2024", "val": 3.4}, {"date": "Sep 2024", "val": 4.7}, {"date": "Feb 2025", "val": 9.2}]}

  **previous_notes**
  {"case_id": "PT-pseudo_4edb17f79e46", "previous_notes": [{"date": "04 Sep 2023", "author": "Dr. S. de Vries (GP)", "text": "Initial evaluation in May 2023 recorded a PSA level of 4.2 ng/mL. Subsequent testing in October revealed an upward trajectory to 6.0 ng/mL, which led to a urology referral for a thorough assessment. A transperineal biopsy was carried out and yielded negative results. The continuing upward trend in current PSA levels has prompted this follow-up consultation."}]}

  **laboratory_results**
  {"case_id": "PT-pseudo_4edb17f79e46", "laboratory_results": [{"name": "PSA", "val": "9.2 ng/mL", "date": "10 Feb 2025", "flag": "H"}, {"name": "Free PSA", "val": "1.42 ng/mL", "date": "10 Feb 2025", "flag": ""}, {"name": "%Free PSA", "val": "15%", "date": "10 Feb 2025", "flag": "L"}, {"name": "Haemoglobin", "val": "14.9 g/dL", "date": "10 Feb 2025", "flag": ""}, {"name": "WBC", "val": "7.0 x10^9/L", "date": "10 Feb 2025", "flag": ""}, {"name": "Platelets", "val": "159 x10^9/L", "date": "10 Feb 2025", "flag": ""}, {"name": "Creatinine", "val": "91 umol/L", "date": "10 Feb 2025", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "10 Feb 2025", "flag": ""}, {"name": "Testosterone", "val": "16.4 nmol/L", "date": "10 Feb 2025", "flag": ""}, {"name": "Alkaline phosphatase", "val": "59 U/L", "date": "10 Feb 2025", "flag": ""}, {"name": "LDH", "val": "172 U/L", "date": "10 Feb 2025", "flag": ""}]}

NOT RETRIEVED
  get_family_history - Not called as per retrieval economy rules.

WHAT THE EVIDENCE SUPPORTS
  FOR sampling this patient now:
  PI-RADS 4 lesion located in the left peripheral zone, approximately 12 mm.
  PSA velocity of 1.51 ng/mL/yr, indicating progression.
  Prior negative biopsy status.

  AGAINST sampling this patient now:
  DRE findings: Normal.
  DRE findings: Normal.

WHERE THIS LEANS
  The retrieved evidence strongly supports sampling due to the combination of a PI-RADS 4 lesion and a rising PSA velocity, which directly addresses the gaps identified by the LLM-1-GAP-ANALYST. This leans towards the statistical prior's suggestion of BIOPSY, as the clinical context now aligns with the need for re-evaluation.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [5] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [6] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the evidence converges on re-sampling due to a PI-RADS 4 lesion (12 mm) and a significant rising PSA velocity of 1.51 ng/mL/yr, which indicates progression. This finding directly addresses the prior negative biopsy status, making the combination of imaging findings and PSA kinetics decisive. The statistical prior suggested biopsy, and the retrieved evidence confirms the clinical need for re-evaluation.

Variables that carried weight: age=noted, dre=noted, psa=decisive, vol=noted, psad=important, pirads=important
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
